Printer Friendly

Bupropion HCl extended-release tablets launched by Dr Reddy's Laboratories in US.

M2 EQUITYBITES-September 7, 2016-Bupropion HCl extended-release tablets launched by Dr Reddy's Laboratories in US


India-based Dr Reddy's Laboratories has introduced Bupropion HCl extended-release tablets, USP (SR) in 100 mg, 150 mg and 200 mg, a therapeutic equivalent generic version of Wellbutrin SR (bupropion HCl) Sustained-Release Tablets, in the United States, it was reported yesterday.

The product has been approved by the United States Food & Drug Administration.

The company's Buproprion SR tablets are offered in all three dosages, in bottle count sizes of 60, 100 and 500.

((Comments on this story may be sent to

COPYRIGHT 2016 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Sep 7, 2016
Previous Article:Destiny Pharma reveals safety, tolerability and efficacy data in US clinical trial of exeporfinium chloride.
Next Article:Argan reports record net income for Q2 2016 year over year.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters